Seeka Limited — Director's Dealing 2022

Aug 25, 2022

==> picture [93 x 25] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		SeekaLimited
Date this disclosure made:		26-Aug-22
Date of last disclosure:		14-Mar-22

Director or senior manager giving disclosure

Director or senior managergiving disclosure
Full name(s):		FredAllan Hutchings
Name of listed issuer:		SeekaLimited
Name of related body corporate (if applicable):		NA
Position held in listed issuer:		Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:		Ordinary Shares
Nature of the affected relevant interest(s):		1) F A Hutchings has the power to exercise the right to voteattached to 20% or more of the voting rights of WalkerNominees Limited, resulting in F Hutchings having a relevantinterest in the Ordinary Shares of Seeka Limited held by WalkerNominees Limited.2) Amwell Holdings Limited. F Hutchings is a director of AmwellHoldings Limited. F Hutchings is the registered holder of 26.1%of the shares in Amwell Holdings Limited in his personalcapacity and a registered holder of 24.9% of the shares inAmwell Holdings Limited jointly with others. As such FHutchings has the power to control the exercise of 20% or moreof the voting rights of Amwell Holdings Limited, resulting in FHutchings having a relevant interest in the Ordinary Shares ofSeeka Limited held by Seeka Share Trustee Limited for and onbehalf of Amwell Holdings Limited.3) Sharesies Nominee Limited holds Ordinary Shares in SeekaLimited for and on behalf of F A Hutchings.4) Sharesies Nominee Limited holds Ordinary Shares in SeekaLimited for and on behalf of Amwell Holdings Limited. FHutchings is a director of Amwell Holdings Limited. F Hutchingsis the registered holder of 26.1% of the shares in AmwellHoldings Limited in his personal capacity and a registeredholder of 24.9% of the shares in Amwell Holdings Limited jointlywith others. As such F Hutchings has the power to control theexercise of 20% or more of the voting rights of Amwell HoldingsLimited, resulting in F Hutchings having a relevant interest in theOrdinary Shares of Seeka Limited held by Sharesies NomineeLimited for and on behalf of Amwell Holdings Limited.
For that relevant interest-
Number held in class before acquisition or disposal:		1) 47,716 Ordinary Shares2) 2,523 Ordinary Shares3) 2,780 Ordinary Shares4)Nil OrdinaryShares
Number held in class after acquisition or disposal:		1) 47,716 Ordinary Shares2) 2,523 Ordinary Shares3) 2,970 Ordinary Shares4)9,987 OrdinaryShares
Current registered holder(s):		1) NA2) NA3) NA4)NA
Registered holder(s) once transfers are registered:		1) Walker Nominees Limited2) Amwell Holdings Limited.3) Sharesies Nominee Limited on behalf of F A Hutchings.4) Sharesies Nominess Limited on behalf of Amwell HoldingsLimited.
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)Type of affected derivative:NAClass of underlyingfinancialproducts:NADetails of affected derivative-The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any):NAA statement as to whether the derivative is cash settled or physically settled:NA
		NA
		NA
The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any):		NA
A statement as to whether the derivative is cash settled or physically settled:		NA

Class of affected quoted financial products:		Ordinary Shares
Nature of the affected relevant interest(s):		1) F A Hutchings has the power to exercise the right to voteattached to 20% or more of the voting rights of WalkerNominees Limited, resulting in F Hutchings having a relevantinterest in the Ordinary Shares of Seeka Limited held by WalkerNominees Limited.2) Amwell Holdings Limited. F Hutchings is a director of AmwellHoldings Limited. F Hutchings is the registered holder of 26.1%of the shares in Amwell Holdings Limited in his personalcapacity and a registered holder of 24.9% of the shares inAmwell Holdings Limited jointly with others. As such FHutchings has the power to control the exercise of 20% or moreof the voting rights of Amwell Holdings Limited, resulting in FHutchings having a relevant interest in the Ordinary Shares ofSeeka Limited held by Seeka Share Trustee Limited for and onbehalf of Amwell Holdings Limited.3) Sharesies Nominee Limited holds Ordinary Shares in SeekaLimited for and on behalf of F A Hutchings.4) Sharesies Nominee Limited holds Ordinary Shares in SeekaLimited for and on behalf of Amwell Holdings Limited. FHutchings is a director of Amwell Holdings Limited. F Hutchingsis the registered holder of 26.1% of the shares in AmwellHoldings Limited in his personal capacity and a registeredholder of 24.9% of the shares in Amwell Holdings Limited jointlywith others. As such F Hutchings has the power to control theexercise of 20% or more of the voting rights of Amwell HoldingsLimited, resulting in F Hutchings having a relevant interest in theOrdinary Shares of Seeka Limited held by Sharesies NomineeLimited for and on behalf of Amwell Holdings Limited.
For that relevant interest-
Number held in class before acquisition or disposal:		1) 47,716 Ordinary Shares2) 2,523 Ordinary Shares3) 2,780 Ordinary Shares4)Nil OrdinaryShares
Number held in class after acquisition or disposal:		1) 47,716 Ordinary Shares2) 2,523 Ordinary Shares3) 2,970 Ordinary Shares4)9,987 OrdinaryShares
Current registered holder(s):		1) NA2) NA3) NA4)NA
Registered holder(s) once transfers are registered:		1) Walker Nominees Limited2) Amwell Holdings Limited.3) Sharesies Nominee Limited on behalf of F A Hutchings.4) Sharesies Nominess Limited on behalf of Amwell HoldingsLimited.
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)Type of affected derivative:NAClass of underlyingfinancialproducts:NADetails of affected derivative-The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any):NAA statement as to whether the derivative is cash settled or physically settled:NA
		NA
		NA
The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any):		NA
A statement as to whether the derivative is cash settled or physically settled:		NA

Maturity date of the derivative (if any): Expiry date of the derivative(if any): The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products:

For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

NA NA NA NA NA NA

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates:

==> picture [5 x 6] intentionally omitted <==

----- Start of picture text ----- 2----- End of picture text -----

Details of transactions requiring disclosure-

Date of transaction: Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details

Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):

• Both transactions are on 22 August 2022. Two transactions: 1. 190 ordinary shares purchased on market by Sharesies Nominee Limited on behalf of F A Hutchings. 2. 9,987 ordinary shares purchased on market by Sharesies Nominee Limited on behalf of Amwell Holdings Limited. NA 1) $760 (190 ordinary shares at $4.00 each) 2) $39,948 (9,987 ordinary shares at $4.00 each)

10,177 ordinary shares

No NA NA

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

Signature of director or officer:

Date of signature:

F Hutchings 26-Aug-22

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature: Name and title of authorised person: